The result is a compound that reduces appetite through GLP-1, enhances insulin sensitivity through GIP, and actively burns stored fat through glucagon receptor engagement
Protocol Overview Concise summary of the GHK-Cu dosage protocol and 100 mg vial calculations
First, determine the nature and duration of the storage error
GLP-1 receptor agonism Binds and activates GLP-1 receptors in the pancreas, brain, and GI tract, mimicking the bodys own post-meal satiety and glucose-regulation signaling
Glutathione levels in the body may be reduced by a number of factors, including poor nutrition, environmental toxins, and stress
These atypical activation processes indicate that intracellular signal transducers may have opportunity to engage the receptor without extracellular stimuli, inducing basal activity